Showing results (241-250 of 520) with videos related to
Sort By:
Pageof 52
Journal of Patient-Reported Outcomes|May 27, 2022
Development and validation of a disease-specific quality of life questionnaire for patients with peripheral artery disease (QOLPAD)Ebru-Berrin Arman, Matthias Augustin, Nicole Mohr, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 7, 2007
Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center studyOliver Schöffski, Matthias Augustin, Jörg Prinz, et al.International Journal of Environmental Research and Public Health|January 11, 2022
Association of Dietary Pattern, Lifestyle and Chronotype with Metabolic Syndrome in Elderly-Lessons from the Population-Based Hamburg City Health StudyClaudia Terschüren, Lukas Damerau, Elina Larissa Petersen, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 8, 2013
Drug supply for psoriasis - results from a national pharmacy networkNadine Franzke, Moritz Montenbruck, Anna Katharina Langenbruch, et al.The Journal of Dermatological Treatment|April 18, 2024
Real-world outcomes and drug survival of brodalumab: results from the German Psoriasis Registry PsoBestLisa Schaeffer, Nesrine Ben-Anaya, Christina Sorbe, et al.Dermatology and Therapy|April 11, 2022
Long-Term Treatment with Dimethyl Fumarate for Plaque Psoriasis in Routine Practice: Good Overall Effectiveness and Positive Effect on Impactful AreasMatthias Augustin, Lilla Landeck, Sebastian Diemert, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 25, 2012
Processes of psoriasis health care in Germany--long-term analysis of data from the statutory health insurancesMatthias Augustin, Gerd Glaeske, Ines Schäfer, et al.The Journal of Dermatological Treatment|June 9, 2025
Severity of psoriasis and its impact on patient-reported outcomes (PROs): real world evidence with brodalumab 210 mg from the LIBERO studyMatthias Augustin, Rudolf E Schopf, Sven R Quist, et al.Acta Dermato-Venereologica|March 28, 2013
Cost-of-illness analysis of patients with chronic hand eczema in routine care in Germany: focus on the impact of occupational diseaseThomas L Diepgen, Sandra Purwins, Jan Posthumus, et al.Dermatology and Therapy|September 14, 2023
Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative ReviewGiampiero Girolomoni, Laura Savage, Paolo Gisondi, et al.Pageof 52